{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:08:00Z","timestamp":1788448080049,"version":"build-2803163510"},"reference-count":168,"publisher":"Elsevier","isbn-type":[{"value":"9780128201893","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000165","name":"Division of Chemistry","doi-asserted-by":"publisher","award":["CHE-1625735"],"award-info":[{"award-number":["CHE-1625735"]}],"id":[{"id":"10.13039\/100000165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.apha.2020.03.003","type":"book-chapter","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T17:54:26Z","timestamp":1588701266000},"page":"311-356","source":"Crossref","is-referenced-by-count":14,"title":["Involvement of muscarinic receptor mechanisms in antidepressant drug action"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apha.2020.03.003_bb0010","first-page":"1","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/syn.1114","article-title":"NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys","volume":"43","author":"Adams","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/bs.apha.2020.03.003_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2015.04.002","article-title":"Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test","volume":"288","author":"Addy","year":"2015","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.apha.2020.03.003_bb0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bcp.2005.12.022","article-title":"A role for AMPA receptors in mood disorders","volume":"71","author":"Alt","year":"2006","journal-title":"Biochemical Pharmacology"},{"issue":"Suppl 1","key":"10.1016\/bs.apha.2020.03.003_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I","article-title":"SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability","volume":"7","author":"Anderson","year":"1998","journal-title":"Depression and Anxiety"},{"issue":"7354","key":"10.1016\/bs.apha.2020.03.003_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0577-y","article-title":"The drug-induced helplessness test: An animal assay for assessing behavioral despair in response to neuroleptic treatment","volume":"190","author":"Ballard","year":"2007","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0045","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/cercor\/bhz187","article-title":"A key role for prefrontocortical small conductance calcium-activated potassium channels in stress adaptation and rapid antidepressant response","volume":"30","author":"Bambico","year":"2019","journal-title":"Cerebral Cortex"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01969561","article-title":"Prejudices in pharmacology and pharmacotherapy. The so-called anticholinergic effect of antidepressants","volume":"7","author":"Bein","year":"1977","journal-title":"Agents and Actions"},{"key":"10.1016\/bs.apha.2020.03.003_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biological Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/bs.apha.2020.03.003_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000138503","article-title":"Muscarinic receptor subtypes and the selectivity of agonists and antagonists","volume":"37","author":"Birdsall","year":"1988","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00442247","article-title":"Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation","volume":"97","author":"Borsini","year":"1989","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0070","first-page":"39","article-title":"Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective","volume":"2","author":"Brocks","year":"1999","journal-title":"Journal of Pharmacy & Pharmaceutical Sciences"},{"issue":"Pt C","key":"10.1016\/bs.apha.2020.03.003_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuropharm.2017.11.024","article-title":"Regulation of neural ion channels by muscarinic receptors","volume":"136","author":"Brown","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0269881118817161","article-title":"Overnight transdermal scopolamine patch administration has no clear effect on cognition and emotional processing in healthy volunteers","volume":"33","author":"Bukala","year":"2019","journal-title":"Journal of Psychopharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0085","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.euroneuro.2016.08.009","article-title":"Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine","volume":"26","author":"Cadeddu","year":"2016","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archpsyc.63.7.741","article-title":"Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder","volume":"63","author":"Cannon","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1999.tb09320.x","article-title":"Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine","volume":"877","author":"Chau","year":"1999","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0306-4522(01)00133-6","article-title":"Nucleus accumbens muscarinic receptors in the control of behavioral depression: Antidepressant-like effects of local M1 antagonist in the Porsolt swim test","volume":"104","author":"Chau","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apha.2020.03.003_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jad.2018.02.075","article-title":"Mortality risk associated with psychological distress and major depression: A population-based cohort study","volume":"234","author":"Chiu","year":"2018","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1016\/bs.apha.2020.03.003_bb0110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2215-0366(19)30292-5","article-title":"US Food and Drug Administration approval of esketamine and brexanolone","volume":"6","author":"Cristea","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1476-5381.1985.tb08921.x","article-title":"Muscarinic receptors discriminated by pirenzepine are involved in the regulation of neurotransmitter release in rat nucleus accumbens","volume":"86","author":"de Belleroche","year":"1985","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11920-018-0891-1","article-title":"Review on the general stability of mood disorder diagnoses along the lifetime","volume":"20","author":"de la Vega","year":"2018","journal-title":"Current Psychiatry Reports"},{"issue":"5","key":"10.1016\/bs.apha.2020.03.003_bb0130","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0031-9384(91)90411-G","article-title":"Effects of diazepam, pentobarbital, scopolamine and the timing of saline injection on learned immobility in rats","volume":"50","author":"De Pablo","year":"1991","journal-title":"Physiology & Behavior"},{"key":"10.1016\/bs.apha.2020.03.003_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-200008000-00005","article-title":"Intravenous versus oral administration of amitriptyline in patients with major depression","volume":"20","author":"Deisenhammer","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"24","key":"10.1016\/bs.apha.2020.03.003_bb0140","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1073\/pnas.90.24.11816","article-title":"Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects","volume":"90","author":"Dewey","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biopsych.2018.12.014","article-title":"Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor","volume":"86","author":"Deyama","year":"2019","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/bs.apha.2020.03.003_bb0150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.euroneuro.2005.03.006","article-title":"Pharmacological modulation of cholinergic brain activity and its reflection in special EEG frequency ranges from various brain areas in the freely moving rat (tele-stereo-EEG)","volume":"15","author":"Dimpfel","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jad.2017.11.041","article-title":"Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response","volume":"227","author":"Dong","year":"2018","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0160","first-page":"143","article-title":"A review of the economic impact of mental illness","volume":"18","author":"Doran","year":"2017","journal-title":"Australian Health Review"},{"issue":"5","key":"10.1016\/bs.apha.2020.03.003_bb0165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","article-title":"Replication of scopolamine's antidepressant efficacy in major depressive disorder: A randomized, placebo-controlled clinical trial","volume":"67","author":"Drevets","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0170","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopsych.2012.09.031","article-title":"Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: A review","volume":"73","author":"Drevets","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1016\/bs.apha.2020.03.003_bb0175","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41380-018-0219-x","article-title":"Cholinergic regulation of mood: From basic and clinical studies to emerging therapeutics","volume":"24","author":"Dulawa","year":"2019","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0180","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14344.1","article-title":"Ketamine and rapid-acting antidepressants: A new era in the battle against depression and suicide","volume":"7","author":"Duman","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/bs.apha.2020.03.003_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2014.03.010","article-title":"Antidepressant treatment history as a predictor of response to scopolamine: Clinical implications","volume":"162","author":"Ellis","year":"2014","journal-title":"Journal of Affective Disorders"},{"issue":"7","key":"10.1016\/bs.apha.2020.03.003_bb0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00210-016-1236-4","article-title":"Learning and memory in the forced swimming test: Effects of antidepressants having varying degrees of anticholinergic activity","volume":"389","author":"Enginar","year":"2016","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/da.22199","article-title":"Clinical relevance of fatigue as a residual symptom in major depressive disorder","volume":"31","author":"Fava","year":"2014","journal-title":"Depression and Anxiety"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0200","first-page":"22","article-title":"SSRI antidepressant medications: Adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: A randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0210","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/2013.jamapsychiatry.60","article-title":"Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder","volume":"70","author":"Furey","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/bs.apha.2020.03.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv028","article-title":"Pretreatment differences in BOLD response to emotional faces correlate with antidepressant response to scopolamine","volume":"18","author":"Furey","year":"2015","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/bs.apha.2020.03.003_bb0220","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/npp.2010.131","article-title":"Scopolamine produces larger antidepressant and antianxiety effects in women than in men","volume":"35","author":"Furey","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.psychres.2012.01.003","article-title":"Baseline mood-state measures as predictors of antidepressant response to scopolamine","volume":"196","author":"Furey","year":"2012","journal-title":"Psychiatry Research"},{"issue":"8","key":"10.1016\/bs.apha.2020.03.003_bb9000","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4088\/JCP.13ac08584","article-title":"Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects","volume":"74","author":"Furey","year":"2013","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2016.01.006","article-title":"The influence of dizocilpine on the reserpine-induced behavioral and neurobiological changes in rats","volume":"614","author":"Gao","year":"2016","journal-title":"Neuroscience Letters"},{"issue":"11","key":"10.1016\/bs.apha.2020.03.003_bb0235","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatric Services"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0240","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02244056","article-title":"Effect of imipramine in the \u201clearned helplessness\u201d model of depression in rats is not mimicked by combinations of specific reuptake inhibitors and scopolamine","volume":"101","author":"Geoffroy","year":"1990","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0245","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00004714-198504000-00003","article-title":"Ketamine: Behavioral effects of subanesthetic doses","volume":"5","author":"Ghoneim","year":"1985","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biopsych.2017.06.017","article-title":"Activity-dependent brain-derived neurotrophic factor release is required for the rapid antidepressant actions of Scopolamine","volume":"83","author":"Ghosal","year":"2018","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cobeha.2016.09.012","article-title":"Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression","volume":"14","author":"Ghosal","year":"2017","journal-title":"Current Opinion in Behavioral Sciences"},{"key":"10.1016\/bs.apha.2020.03.003_bb0260","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2008.11.015","article-title":"Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects","volume":"116","author":"Gibbons","year":"2009","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1781(95)02700-7","article-title":"No antidepressant effect of biperiden compared with placebo in depression: A double-blind 6-week clinical trial","volume":"58","author":"Gillin","year":"1995","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0270","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.1991.01810270076011","article-title":"The cholinergic rapid eye movement induction test with arecoline in depression","volume":"48","author":"Gillin","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0275","series-title":"Burger's medicinal chemistry and drug discovery","article-title":"Antidepressants","author":"Glennon","year":"2020"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(92)90814-K","article-title":"Modification of muscarinic acetylcholine receptors in the rat brain following chronic immobilization stress: An autoradiographic study","volume":"223","author":"Gonz\u00e1lez","year":"1992","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0285","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(87)90207-1","article-title":"Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons","volume":"415","author":"Hand","year":"1987","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2020.03.003_bb0290","article-title":"Rapid acting antidepressants in chronic stress models: Molecular and cellular mechanisms","volume":"1","author":"Hare","year":"2017","journal-title":"Chronic Stress (Thousand Oaks"},{"issue":"43","key":"10.1016\/bs.apha.2020.03.003_bb0295","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.apha.2020.03.003_bb0300","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/cercor\/bhp161","article-title":"Activation of muscarinic acetylcholine receptors induces a nitric oxide-dependent long-term depression in rat medial prefrontal cortex","volume":"20","author":"Huang","year":"2010","journal-title":"Cerebral Cortex"},{"issue":"Suppl 1","key":"10.1016\/bs.apha.2020.03.003_bb0305","first-page":"5","article-title":"Muscarinic acetylcholine receptors: Structure, function subtypes and therapeutic perspectives","volume":"63","author":"Hulme","year":"1987","journal-title":"Postgraduate Medical Journal"},{"issue":"6","key":"10.1016\/bs.apha.2020.03.003_bb0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11920-011-0239-6","article-title":"Serendipity strikes again: Scopolamine as an antidepressant agent in bipolar depressed patients","volume":"13","author":"Janowsky","year":"2011","journal-title":"Current Psychiatry Reports"},{"issue":"7778","key":"10.1016\/bs.apha.2020.03.003_bb0315","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic-adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0320","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ajmg.1320540412","article-title":"Is cholinergic sensitivity a genetic marker for the affective disorders?","volume":"54","author":"Janowsky","year":"1994","journal-title":"American Journal of Medical Genetics"},{"issue":"2\/3","key":"10.1016\/bs.apha.2020.03.003_bb0325","first-page":"297","article-title":"Adrenergic-cholinergic balance and the treatment of affective disorders","volume":"7","author":"Janowsky","year":"1982","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0330","first-page":"400","article-title":"Effect of scopolamine on depression in mice","volume":"46","author":"Ji","year":"2011","journal-title":"Yao Xue Xue Bao"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0335","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12031-018-1124-0","article-title":"Role of a VGF\/BDNF\/TrkB autoregulatory feedback loop in rapid-acting antidepressant efficacy","volume":"68","author":"Jiang","year":"2018","journal-title":"Journal of Molecular Neuroscience"},{"issue":"7","key":"10.1016\/bs.apha.2020.03.003_bb0340","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00008877-200311000-00003","article-title":"Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats","volume":"14","author":"Jutkiewicz","year":"2003","journal-title":"Behavioural Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2020.03.003_bb0345","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-1019597","article-title":"The anticholinergic biperiden in depressive disorders","volume":"14","author":"Kasper","year":"1981","journal-title":"Pharmacopsychiatria"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0350","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0149-7634(81)90008-7","article-title":"Amitriptyline and scopolamine in an animal model of depression","volume":"5","author":"Katz","year":"1981","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"6","key":"10.1016\/bs.apha.2020.03.003_bb0355","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1520-6394(1996)4:6<257::AID-DA1>3.0.CO;2-9","article-title":"Onset of antidepressant activity: Reexamining the structure of depression and multiple actions of drugs","volume":"4","author":"Katz","year":"1996","journal-title":"Depression and Anxiety"},{"key":"10.1016\/bs.apha.2020.03.003_bb0360","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.npp.1300341","article-title":"Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression","volume":"29","author":"Katz","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0365","article-title":"Esketamine: A glimmer of hope in treatment-resistant depression","author":"Kaur","year":"2019","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0370","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1172\/JCI111517","article-title":"Central cholinergic stimulation causes adrenal epinephrine release","volume":"74","author":"Kennedy","year":"1984","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"10.1016\/bs.apha.2020.03.003_bb0375","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4088\/JCP.12m07706","article-title":"Oral scopolamine augmentation in moderate to severe major depressive disorder: A randomized, double-blind, placebo-controlled study","volume":"73","author":"Khajavi","year":"2012","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0380","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3949\/ccjm.73.4.351","article-title":"Side effects of antidepressants: An overview","volume":"73","author":"Khawam","year":"2006","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2020.03.003_bb0385","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(81)90269-7","article-title":"Effects of antidepressants in the rat forced swimming test","volume":"72","author":"Kitada","year":"1981","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0390","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2014.05.065","article-title":"Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats","volume":"271","author":"Koike","year":"2014","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.apha.2020.03.003_bb0395","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behavioural Brain Research"},{"issue":"35\u201336","key":"10.1016\/bs.apha.2020.03.003_bb0400","first-page":"1135","article-title":"Treatment of depressive states with an iminodibenzyl derivative (G 22355)","volume":"87","author":"Kuhn","year":"1957","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0405","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"14","author":"Lally","year":"2014","journal-title":"Translational Psychiatry"},{"issue":"5","key":"10.1016\/bs.apha.2020.03.003_bb0410","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0269881114568041","article-title":"Neural correlates of change in major depressive disorder anhedonia following open-label ketamine","volume":"29","author":"Lally","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb9050","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0415","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2016.09.011","article-title":"Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures","volume":"111","author":"Lepack","year":"2016","journal-title":"Neuropharmacology"},{"issue":"5994","key":"10.1016\/bs.apha.2020.03.003_bb0420","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0425","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2017.2432","article-title":"Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: A systematic review and meta-analysis","volume":"74","author":"Locher","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0430","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0435","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(88)90067-2","article-title":"Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test","volume":"158","author":"Mancinelli","year":"1988","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0440","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/1871527316666170309142646","article-title":"Further evaluation of mechanisms associated with the antidepressant-like signature of scopolamine in mice","volume":"16","author":"Martin","year":"2017","journal-title":"CNS and Neurological Disorders \u2013 Drug Targets"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0445","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw055","article-title":"The effects of vortioxetine on cognitive function in patients with major depressive disorder: A meta-analysis of three randomized controlled trials","volume":"19","author":"McIntyre","year":"2016","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb9010","article-title":"Simultaneous EEG\/fMRI recorded during ketamine infusion in patients with major depressive disorder","volume":"99","author":"McMillan","year":"2019","journal-title":"Progress in Neuropsychopharmacology & Biology Psychiatry"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0450","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0022-3565(25)38638-6","article-title":"Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine","volume":"268","author":"Meltzer","year":"1994","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2020.03.003_bb0455","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0306-4522(89)90377-1","article-title":"The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens of the rat","volume":"31","author":"Meredith","year":"1989","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2020.03.003_bb0460","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(98)00748-3","article-title":"Amygdala-kindled and electroconvulsive seizures alter hippocampal expression of the m1 and m3 muscarinic cholinergic receptor genes","volume":"810","author":"Mingo","year":"1998","journal-title":"Brain Research"},{"issue":"12","key":"10.1016\/bs.apha.2020.03.003_bb0465","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biopsych.2012.09.006","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","volume":"73","author":"Monteggia","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0470","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.biopsych.2013.08.011","article-title":"Scopolamine and ketamine: Evidence of convergence?","volume":"74","author":"Monteggia","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101640","article-title":"Management strategies for antidepressant-related sexual dysfunction: A clinical approach","volume":"8","author":"Montejo","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"12","key":"10.1016\/bs.apha.2020.03.003_bb0480","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2019.10.007","article-title":"Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders","volume":"40","author":"Moran","year":"2019","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0485","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002130100849","article-title":"Antidepressant-like effects of aniracetam in aged rats and its mode of action","volume":"158","author":"Nakamura","year":"2001","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2020.03.003_bb0490","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s00213-019-05294-0","article-title":"Additive interaction between scopolamine and nitric oxide agents on immobility in the forced swim test but not exploratory activity in the hole-board","volume":"236","author":"Nasehi","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0495","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2015.06.012","article-title":"Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors","volume":"82","author":"Navarria","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apha.2020.03.003_bb9015","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaa027","article-title":"Managing esketamine treatment frequency toward successful outcomes: Analysis of phase 3 data","author":"Nijs","year":"2020","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0500","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0149-7634(05)80230-1","article-title":"The flinders sensitive line rats: A genetic animal model of depression","volume":"17","author":"Overstreet","year":"1993","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0505","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02245589","article-title":"Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders sensitive line rats as an animal model of depression","volume":"121","author":"Overstreet","year":"1995","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb9020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/WNF.0b013e318290b8c8","article-title":"Scopolamine as an antidepressant","volume":"36","author":"Pae","year":"2013","journal-title":"Clinical Neuropharmacology"},{"issue":"Pt B","key":"10.1016\/bs.apha.2020.03.003_bb0510","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pnpbp.2017.06.022","article-title":"The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test","volume":"79","author":"Pa\u0142ucha-Poniewiera","year":"2017","journal-title":"Progress in Neuropsychopharmacology & Biology Psychiatry"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0515","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ijnp\/pyy051","article-title":"Neurophysiological changes associated with antidepressant response to ketamine not observed in a negative trial of scopolamine in major depressive disorder","volume":"22","author":"Park","year":"2019","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb9025","first-page":"1","article-title":"Transdermal scopolamine: A review of its effects upon motion sickness, psychological performance, and physiological functioning","volume":"60","author":"Parrott","year":"1989","journal-title":"Aviation, Space, and Environmental Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0520","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3565(25)38715-X","article-title":"Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments","volume":"269","author":"Paul","year":"1994","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2020.03.003_bb0525","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2016.03.051","article-title":"Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice","volume":"620","author":"Petryshen","year":"2016","journal-title":"Neuroscience Letters"},{"issue":"Pt A","key":"10.1016\/bs.apha.2020.03.003_bb0530","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2016.05.010","article-title":"Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB\/cJ mice","volume":"112","author":"Pham","year":"2017","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2020.03.003_bb0535","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01611860","article-title":"Immunocytochemical localization of choline acetyltransferase in rat ventral striatum: a light and electron microscopic study","volume":"15","author":"Phelps","year":"1986","journal-title":"Journal of Neurocytology"},{"issue":"5","key":"10.1016\/bs.apha.2020.03.003_bb0540","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: A randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0545","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression","volume":"45","author":"Phillips","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0550","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuropharm.2018.08.022","article-title":"The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice","volume":"141","author":"Podkowa","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0555","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2016.08.031","article-title":"Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495","volume":"111","author":"Podkowa","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0560","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuroscience.2006.03.043","article-title":"Behavioral depression in the swim test causes a biphasic, long-lasting change in accumbens acetylcholine release, with partial compensation by acetylcholinesterase and muscarinic-1 receptors","volume":"141","author":"Rada","year":"2006","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/bs.apha.2020.03.003_bb0565","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/mp.2017.36","article-title":"Identifying fast-onset antidepressants using rodent models","volume":"22","author":"Ramaker","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0570","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00413329","article-title":"Amitriptyline and nortriptyline as antagonists of central and peripheral cholinergic activation","volume":"16","author":"Rathbun","year":"1963","journal-title":"Psychopharmacologia"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3565(24)37561-5","article-title":"Muscarinic receptors regulate extracellular glutamate levels in the rat striatum: An in vivo microdialysis study","volume":"286","author":"Rawls","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2020.03.003_bb0580","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jad.2019.04.018","article-title":"Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders","volume":"252","author":"Rhee","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0585","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0196-9781(82)90093-6","article-title":"Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans","volume":"3","author":"Risch","year":"1982","journal-title":"Peptides"},{"key":"10.1016\/bs.apha.2020.03.003_bb0590","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR_D report","volume":"163","author":"Rush","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0595","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/fcp.12319","article-title":"Average spectral power changes at the hippocampal electroencephalogram in schizophrenia model induced by ketamine","volume":"32","author":"Sampaio","year":"2018","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2020.03.003_bb0600","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0605","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2018.12.001","article-title":"Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats","volume":"313","author":"Shokry","year":"2018","journal-title":"Experimental Neurology"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0610","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/bcp.13699","article-title":"Detecting a potential safety signal of antidepressants and type 2 diabetes: A pharmacovigilance-pharmacodynamic study","volume":"84","author":"Siafis","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0615","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S2215-0366(19)30533-4","article-title":"Approval of esketamine for treatment-resistant depression","volume":"7","author":"Singh","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0620","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/0253-7613.161260","article-title":"Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice","volume":"47","author":"Singh","year":"2015","journal-title":"Indian Journal of Pharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2020.03.003_bb0625","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","article-title":"Glutamate-based antidepressants: 20 years on","volume":"30","author":"Skolnick","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"issue":"6","key":"10.1016\/bs.apha.2020.03.003_bb0630","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00702-011-0756-9","article-title":"Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice","volume":"119","author":"Socala","year":"2012","journal-title":"Journal of Neural Transmission (Vienna)"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0635","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1254\/jphs.13145FP","article-title":"Test-retest paradigm of the forced swimming test in female mice is not valid for predicting antidepressant-like activity: Participation of acetylcholine and sigma-1 receptors","volume":"123","author":"Su","year":"2013","journal-title":"Journal of Pharmacological Sciences"},{"issue":"12","key":"10.1016\/bs.apha.2020.03.003_bb0640","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s11064-019-02891-5","article-title":"A selective M(1) and M(3) receptor antagonist, penehyclidine hydrochloride, exerts antidepressant-like effect in mice","volume":"44","author":"Sun","year":"2019","journal-title":"Neurochemical Research"},{"key":"10.1016\/bs.apha.2020.03.003_bb0645","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.21","article-title":"Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model","volume":"6","author":"Sun","year":"2016","journal-title":"Translational Psychiatry"},{"key":"10.1016\/bs.apha.2020.03.003_bb0650","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pscychresns.2016.06.005","article-title":"Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder","volume":"254","author":"Szczepanik","year":"2016","journal-title":"Psychiatry Research: Neuroimaging"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0655","first-page":"129","article-title":"Relationship between learning behavior and genetic factor on immobility shown during forced swimming test","volume":"17","author":"Tadano","year":"1997","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"10.1016\/bs.apha.2020.03.003_bb0660","doi-asserted-by":"crossref","first-page":"116695","DOI":"10.1016\/j.lfs.2019.116695","article-title":"The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers","volume":"233","author":"Tang","year":"2019","journal-title":"Life Sciences"},{"issue":"7594","key":"10.1016\/bs.apha.2020.03.003_bb0665","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature17188","article-title":"Crystal structures of the M1 and M4 muscarinic acetylcholine receptors","volume":"531","author":"Thal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2020.03.003_bb0670","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroscience.2018.11.053","article-title":"Sex differences in the temporal neuromolecular and synaptogenic effects of the rapid-acting antidepressant drug ketamine in the mouse brain","volume":"398","author":"Thelen","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apha.2020.03.003_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"European Journal of Pharmacology"},{"issue":"18","key":"10.1016\/bs.apha.2020.03.003_bb0680","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1523\/JNEUROSCI.20-18-07067.2000","article-title":"Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain","volume":"20","author":"Tsukada","year":"2000","journal-title":"The Journal of Neuroscience"},{"issue":"12","key":"10.1016\/bs.apha.2020.03.003_bb0685","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S2215-0366(19)30394-3","article-title":"Esketamine for treatment-resistant depression: Seven concerns about efficacy and FDA approval","volume":"6","author":"Turner","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"10.1016\/bs.apha.2020.03.003_bb0690","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1460-9568.2004.03278.x","article-title":"Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain","volume":"19","author":"Valjent","year":"2004","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.apha.2020.03.003_bb0695","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2014.05.063","article-title":"The catecholaminergic\u2013cholinergic balance hypothesis of bipolar disorder revisited","volume":"753","author":"Van Enkhuizen","year":"2015","journal-title":"European Journal of Pharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2020.03.003_bb0700","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.biopsych.2013.04.025","article-title":"Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses","volume":"74","author":"Voleti","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"Pt. 21","key":"10.1016\/bs.apha.2020.03.003_bb0710","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1113\/jphysiol.2009.174821","article-title":"Activation of M2 muscarinic receptors leads to sustained suppression of hippocampal transmission in the medial prefrontal cortex","volume":"587","author":"Wang","year":"2009","journal-title":"The Journal of Physiology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172870","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","volume":"190","author":"Wei","year":"2020","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0720","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-005-0048-x","article-title":"A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test","volume":"182","author":"West","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0725","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2018.11.007","article-title":"A new generation of antidepressants: An update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate\/GABA neurotransmitter systems","volume":"24","author":"Wilkinson","year":"2018","journal-title":"Drug Discovery Today"},{"key":"10.1016\/bs.apha.2020.03.003_bb9030","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/0024-3205(88)90345-1","article-title":"Central oxotremorine antagonist properties of pirenzepine","volume":"42","author":"Witkin","year":"1988","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb0730","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF00439454","article-title":"Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys","volume":"97","author":"Witkin","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0735","series-title":"Advances in behavioral pharmacology","first-page":"79","article-title":"Behavioral pharmacology of compounds affecting muscarinic cholinergic receptors","volume":"Vol. 7","author":"Witkin","year":"1990"},{"key":"10.1016\/bs.apha.2020.03.003_bb0740","series-title":"Neuropsychotherapeutics, advances in pharmacology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.apha.2019.03.002","article-title":"Rapid-acting antidepressants","volume":"Vol. 86","author":"Witkin","year":"2019"},{"key":"10.1016\/bs.apha.2020.03.003_bb0745","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.116.233627","article-title":"The rapidly-acting antidepressant ketamine rapidly engages dopaminergic mood circuits","volume":"358","author":"Witkin","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0750","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/jpet.114.216804","article-title":"The M1 and M2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly-acting antidepressant scopolamine","volume":"351","author":"Witkin","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb9035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/jpet.116.238121","article-title":"Comparative effects of LY3020371, a potent and selective mGlu2\/3 receptor antagonist, and ketamine, a non-competitive NMDA receptor antagonist, in rodents: Evidence supporting use for the treatment of depression","volume":"361","author":"Witkin","year":"2017","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"7","key":"10.1016\/bs.apha.2020.03.003_bb0755","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1172\/JCI85033","article-title":"GABA interneurons mediate the rapid antidepressant-like effects of scopolamine","volume":"126","author":"Wohleb","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb9045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570159X14666160309114549","article-title":"Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine","volume":"15","author":"Wohleb","year":"2017","journal-title":"Current Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0760","doi-asserted-by":"crossref","first-page":"118","DOI":"10.9758\/cpn.2015.13.1.118","article-title":"Combination of nitrous oxide with isoflurane or scopolamine for treatment-resistant major depression","volume":"13","author":"Yang","year":"2015","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0765","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (r)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.apha.2020.03.003_bb0770","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ijnp\/pyx080","article-title":"The requirement of L-type voltage-dependent calcium channel (L-VDCC) in the rapid-acting antidepressant-like effects of scopolamine in mice","volume":"21","author":"Yu","year":"2018","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0775","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuropharm.2017.12.028","article-title":"Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice","volume":"131","author":"Yu","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2020.03.003_bb0780","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.psychres.2018.12.015","article-title":"BDNF mediates the protective effects of scopolamine in reserpine-induced depression-like behaviors via up-regulation of 5-HTT and TPH1","volume":"271","author":"Yu","year":"2019","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/bs.apha.2020.03.003_bb9150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apha.2020.03.003_bb0785","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1016\/bs.apha.2020.03.003_bb0790","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0091-3057(90)90097-2","article-title":"Chronic stress and memory: Implication of the central cholinergic system","volume":"36","author":"Zerbib","year":"1990","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"1","key":"10.1016\/bs.apha.2020.03.003_bb0795","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13063-018-3132-3","article-title":"Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: Study protocol for a randomized controlled trial","volume":"20","author":"Zhou","year":"2019","journal-title":"Trials"},{"key":"10.1016\/bs.apha.2020.03.003_bb0800","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2017.02.004","article-title":"The antidepressant-like effects of biperiden may involve BDNF\/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice","volume":"157","author":"Zhou","year":"2017","journal-title":"Pharmacology, Biochemistry, and Behavior"}],"container-title":["Advances in Pharmacology","Rapid Acting Antidepressants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358920300211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358920300211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:28:02Z","timestamp":1762360082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358920300211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128201893"],"references-count":168,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2020.03.003","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}